Fundraising FoxSeonix Bio
1 known investors
Find your way into Seonix Bio
Sign up to see every warm intro you have to Seonix Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Seonix Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Seonix develops a genetic risk score to identify individuals at elevated risk of glaucoma, serving eye health professionals, patients, and researchers. The company uses large-scale genetic datasets and advanced techniques for clinical risk prediction to help prevent vision loss.
Founders & leadership
JC
Jamie CraigCo-FounderJamie Craig is Chair and Academic Head of Ophthalmology at Flinders University and a Consultant Ophthalmologist with expertise in glaucoma genetics and clinical translation. He founded the Australian and New Zealand Registry of Advanced Glaucoma and leads research on genetic susceptibility to glaucoma and other eye diseases, including genome-wide association studies to identify genes linked to glaucoma risk.
AH
Alex HewittCo-Founder
N
NickChief Executive Officer
Investors · 1
In the news
Frequently asked questions
- What does Seonix Bio do?
- Seonix develops a genetic risk score to identify individuals at elevated risk of glaucoma, serving eye health professionals, patients, and researchers. The company uses large-scale genetic datasets and advanced techniques for clinical risk prediction to help prevent vision loss.
- Who founded Seonix Bio?
- Seonix Bio was founded by Johnathon Matthews, Jamie Craig, Alex Hewitt.
- Who are Seonix Bio's investors?
- Seonix Bio's investors include South Australian Venture Capital Fund.